Strona 3 - Najlepsi lekarze wykonujący terapię celowaną – TOP 65 lekarzy

Dr. Mariam Mohammed Hussein Abu Zeid is a clinical oncologist. She treats solid tumors and hematologic cancers. She earned her MBBCh from Ain Shams University in 2007 (Excellent). She completed a Master’s in Clinical Oncology and Nuclear Medicine in 2011 (Very Good). She received a Ph.D. in 2018 and an ESMO Certificate in 2015.

She leads and monitors clinical trials. Her work includes data collection and analysis. She administers chemotherapy and manages treatment toxicities. She also plans care with multidisciplinary teams. Her experience includes Ain Shams University Hospitals (2009–2012), the International Medical Center (2012–2014), and Wadi El Nile Hospital (2015–2019). Her roles covered diagnosis and staging, supportive care, quality improvement, and screening. She educates patients and families about the diagnosis, treatment options, and palliative care.

Dyrektor kliniczny Interdyscyplinarnego Centrum Leczenia Piersi w Kliniken Essen-Mitte – Sherko Kuemmel kieruje zaawansowanymi badaniami i leczeniem raka piersi.

• 322 recenzowane publikacje na temat raka piersi
• Członek Zarządu AGO – współtworzy wytyczne dotyczące leczenia raka piersi
• Prowadzi międzynarodowe badania kliniczne jako Global PI
• Członek wydziału ESMO w zakresie edukacji o raku piersi

Prof. Ben Boursi is a physician in the Gastrointestinal Cancer Department at Sheba Medical Center. He specializes in internal medicine, medical oncology, and cancer epidemiology. He is board certified in internal medicine and medical oncology. He earned a B.Med.Sc (summa cum laude) and an MD (magna cum laude) from Tel Aviv University.

He completed clinical and research fellowships in GI oncology and cancer epidemiology at the University of Pennsylvania. He also completed electives at MD Anderson and Mayo Clinic. He founded the ECOG-ACRIN Microbiome Working Group. His microbiome-oncology research has been published in leading journals, including Science, and highlighted by ASCO.

He developed predictive models for early diagnosis of colorectal and pancreatic cancers. These models are now in clinical evaluation. He holds an academic appointment at Tel Aviv University. He is also an Associate Scholar at the University of Pennsylvania.

Dr. Lucía González Cortijo is a medical oncologist with more than 20 years of experience. She has led the Medical Oncology Department at Hospital Universitario Quirónsalud Madrid since 2020. Her focus areas include breast and gynecologic cancers. She also works in precision oncology, targeted therapies, and immunotherapy.

She has been Principal Investigator in more than 20 Phase II–III clinical trials. She has also served as sub-investigator in over 50 international trials. She previously worked at Quirónsalud Madrid from 2009 to 2020. Before that, she was at MD Anderson Cancer Center Madrid from 2002 to 2009.

She holds an MD and a PhD (cum laude) from the Autonomous University of Madrid. She completed her Medical Oncology specialty training at Hospital 12 de Octubre. She also earned a Master’s in Molecular Oncology. She is a member of SEOM, ESMO, ASCO, and GEICAM. She is a university lecturer.

Dr Erdogan, specjalizujący się w zaawansowanych procedurach endoskopowych, wnosi swoje doświadczenie w zakresie ECPW (ERCP), EUS i leczenia IBD (nieswoistych zapaleń jelit) w szpitalu İstinye University Liv Hospital Topkapı.

• Odbył staż kliniczny (fellowship) w dziedzinie gastroenterologii w Szpitalu Miejskim w Ankarze
• Opublikował liczne artykuły badawcze dotyczące leczenia nieswoistych zapaleń jelit
• Doświadczony w przezustnej miotomii endoskopowej (POEM) i endoskopowej dyssekcji podśluzówkowej (ESD)
• Aktywny autor artykułów w recenzowanych czasopismach naukowych z dziedziny gastroenterologii

Professor Raanan Berger, MD PhD, is a medical oncologist and radiotherapist. He is Director of the Cancer Center at Sheba Medical Center and heads its clinical research unit. He was listed in Forbes Israel’s “Best Doctors” (2025). He leads the genitourinary oncology program with a focus on prostate cancer. His care includes systemic therapy and radiotherapy in a multidisciplinary, patient-centered model.

He is board-certified in oncology. He earned his MD and PhD at Tel Aviv University and completed his clinical training at Sheba. He then completed a postdoctoral fellowship at Dana-Farber/Harvard, focusing on prostate cancer with Dr. Philip Kantoff and molecular oncology in Dr. William C. Hahn’s lab. He is a member of ESMO and ASCO. He has co-authored more than 20 peer-reviewed papers, including studies on outcomes in high- versus very high-risk prostate cancer and on BRCA1/2 in large cohorts.

Dr. Nir Kleinmann, MD, directs the Endourology and Kidney Stones Unit at Sheba Medical Center. He is an expert in minimally invasive urology and urologic oncology. His focus is the kidney and upper urinary tract. He was named among Israel’s Best Doctors for 2025–2026 by Forbes and ResultMed.

He is a pioneer of kidney‑sparing laser surgery. He uses a dual‑laser system with neodymium and holmium for complex tumors. His expertise includes UTUC, kidney and prostate cancer, kidney stones, and BPH.

His research includes the OLYMPUS trial on chemoablation for UTUC. He has more than 60 publications.

He is an Israeli board‑certified urologist. He is a Fellow of the American Endourology Society and a member of the Israeli Urological Association and the EAU. He completed fellowships in Endourology and Minimally Invasive Surgery at Thomas Jefferson University. He also completed a fellowship in Kidney Cancer Research at McMaster University.

Ordynator Centrum Onkologii w Centrum Medycznym Assuta – wiodący ekspert w terapii celowanej.

• Specjalizuje się w precyzyjnych terapiach onkologicznych
• Bogate doświadczenie w spersonalizowanych terapiach przeciwnowotworowych
• Pracuje w jednym z najlepszych ośrodków onkologicznych w Izraelu

Dr. Yaacov Lawrence, MA, MBBS, MRCP, is Chair of Radiation Oncology at Sheba Medical Center. He has nearly 30 years of experience in precision radiation oncology and neuro-oncology.

He is an expert in advanced radiation therapy and radiosurgery. He performs stereotactic radiosurgery for brain tumors. He leads Sheba’s GI Cancer Program in gastrointestinal oncology. He also provides precision care for lung and prostate cancers. He pioneered celiac plexus radiosurgery for severe pain from pancreatic cancer.

Training and credentials: MA and MBBS (Cambridge and UCLH); MRCP (RCP); Radiation Oncology fellowship (Thomas Jefferson University). Honors include the ASCO Young Investigator Award and Fellow of ASTRO (FASTRO). He has authored over 280 publications. He is Director of the Center for Translational Radiation Oncology and an Associate Professor at Tel Aviv University.

Dr. Eytan Aharon Ben‑Ami, MD, is a Senior Physician in the Sarcoma and Bone Oncology Service at Sheba Medical Center. He heads the Oncology Division and the Early-Phase Clinical Trials Unit. He founded the Sheba Clinical Research Organization. He is an academic affiliate at Tel Aviv University.

He specializes in sarcomas and primary bone tumors, including soft tissue sarcoma, liposarcoma, leiomyosarcoma, and osteosarcoma. He leads Phase I trials in targeted therapy and immunotherapy. He designs personalized treatment plans for rare cancers. He also develops patient-centered programs, including pilots in advanced immunotherapy delivery.

He completed a fellowship in Sarcoma and Bone Oncology at the Dana-Farber Cancer Institute/Harvard Cancer Center. He has authored more than 40 publications on early detection, molecular and viral mechanisms, and new cancer therapies.

Professor Jair Bar, MD, PhD, is a thoracic oncologist and Deputy Director of the Cancer Center at Sheba Medical Center. He leads the Thoracic Oncology Unit. He treats lung cancer, including advanced non-small cell cases. His care includes medical oncology, radiotherapy, immunotherapy, and targeted therapy.

He runs a translational research lab focused on resistance to immunotherapy. He has published on exhaled-breath cancer metabolism and on angiogenesis inhibition in lung cancer.

He has chaired the Israel Lung Cancer Group since 2003. He is a member of the Israel Society of Clinical Oncology and Radiotherapy, the American Society of Clinical Oncology, and the American Association for Cancer Research. He is board-certified in Medical Oncology and Radiotherapy Oncology. He is a Senior Lecturer at Tel Aviv University.

Dr. Emad Shash, M.B.B.Ch, MSc, M.D., is a medical oncologist. He is the Medical Director of the Breast Comprehensive Cancer Hospital at NCI. He leads the Medical Oncology Department and is the Breast Program Director at Shifaa Al Orman Cancer Hospital in Luxor. His clinical focus includes breast, gynecologic, genitourinary, thoracic, gastrointestinal, and rare cancers. He specializes in systemic therapy, including chemotherapy, targeted therapy, and immunotherapy.

He served as coordinating research physician and medical lead at the EORTC from 2011 to 2015. Since 2008, he has contributed to more than 70 international oncology trials as a coordinator, sub-investigator, principal investigator, and sponsor medical monitor. Credentials include M.B.B.Ch (2004), MSc (2010), MD (2015), and the EORTC Certificate of Excellence (2015). He also holds a Diploma in Hospital Quality Management & Patient Safety (JCI/57357, 2017). He is a Fellow of the EIO. He is a member of ESMO (panel voting), ESGO, and ASCO (IAC), and serves on the ECRIN board.

Dr Shaunak specjalizuje się w molekularnych podstawach nowotworów i posiada doświadczenie w terapiach celowanych, prezentując badania na sympozjum ASCO dotyczącym nowotworów układu pokarmowego.

• Ukończył DNB w dziedzinie onkologii klinicznej w Indraprastha Apollo Hospital
• Zaprezentował badania nad rakiem żołądka na sympozjum ASCO
• Wykładał w Międzynarodowej Zimowej Szkole Onkologii w AIIMS
• Pracuje w HCG Manavata Cancer Centre

35 lat specjalizacji w zakresie ciąż wysokiego ryzyka – dr Vatsa zajmuje się złożonymi przypadkami w Fortis Memorial Research Institute.

• Ekspert w dziedzinie operacji endoskopowych i metod diagnostycznych
• Specjalizuje się w leczeniu ciąży pozamacicznej i poronień
• Autor licznych artykułów z zakresu onkologii ginekologicznej
• Członek Indyjskiego Stowarzyszenia Ginekologów

Dr Vinod Raina specjalizuje się w terapii celowanej w Fortis Gurgaon, wnosząc ukierunkowaną wiedzę specjalistyczną w leczenie raka.

• Onkolog medyczny z bogatym doświadczeniem w chemioterapii
• Specjalizuje się w podejściach medycyny precyzyjnej
• Praktykuje w Fortis Gurgaon, wiodącej placówce opieki zdrowotnej

Uznany przez magazyn FOCUS za jednego z wiodących urologów w Niemczech – profesor Truss specjalizuje się w leczeniu raka prostaty w akredytowanym „Ośrodku Leczenia Karcinomy Prostaty”.

• 30 lat doświadczenia w urologii
• Stosuje techniki wspomagane robotycznie w celu precyzyjnej, minimalnie inwazyjnej chirurgii prostaty
• Publikował w czołowych czasopismach urologicznych w Europie i USA
• Laureat Nagrody Jacka Lapidesa (Jack Lapides Prize) i Nagrody Kongresu EAU
• Kieruje oddziałem urologii w Klinice Dortmund

Profesor Jorg Groticke kieruje Centrum Onkologii i Hematologii w Szpitalu Bremen Mitte, specjalizując się w nowotworach hematologicznych i nowotworach przewodu pokarmowego.

• Specjalista w dziedzinie immunologii od 1987 roku
• Starszy lekarz w Centrum Chorób Wewnętrznych od 2007 roku
• Członek Niemieckiego Towarzystwa Hematologii i Onkologii Medycznej
• Wygłasza wykłady na temat innowacyjnych terapii onkologicznych w Bremeńskim Towarzystwie Onkologicznym

Dr Joan Albanell Mestres kieruje programem leczenia raka piersi w HM Delfos i opublikował ponad 120 artykułów cytowanych ponad 9000 razy.

• MBBS (licencjat medycyny, licencjat chirurgii) uzyskany na Uniwersytecie Autonomicznym w Barcelonie
• Rezydencja w klinice Vall d'Hebron
• Prowadził badania nad telomerazą w Nowym Jorku
• Dyrektor ds. badań nad rakiem w Del Mar
• Wiodący członek GEICAM, CIBERONC, AIECA, SEOM

Dr Raj Nagarkar przeprowadził ponad 50 000 operacji onkologicznych i kierował ponad 200 badaniami klinicznymi, koncentrując się na onkologii chirurgicznej piersi i klatki piersiowej.

• Szkolił się w Tata Memorial Hospital oraz Royal College of Surgeons w Edynburgu
• Specjalizuje się w onkologii chirurgicznej piersi i klatki piersiowej
• Profesor nadspecjalizacji DNB w zakresie onkologii chirurgicznej
• 19 lat doświadczenia w onkologii chirurgicznej
• Liczne publikacje międzynarodowe i krajowe